Cure My Disease

Don't miss your cure!

 Log in / Sign up

New online program aims to help african americans take control of diabetes

NCT ID NCT03855449

Disease control Sponsor: University of Kansas Medical Center Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This pilot study tested a web-based version of the DECIDE program, called eDECIDE, which teaches problem-solving skills to help African Americans manage type 2 diabetes. The study involved 36 participants and compared the online program to the traditional in-person group sessions over 18 weeks. The main goal was to see if the web-based approach could help lower blood sugar levels (HbA1c) by at least 0.5%.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
eDECIDE web-based problem-solving self-management program
What this could lead to
If it works, this could provide an effective online tool to help African Americans with type 2 diabetes better manage their condition and improve blood sugar levels.
What could go wrong
This is a very small pilot study (36 participants) with no phase designation, so results may not apply broadly. The web-based version is still being developed and tested.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

36 people

The number who actually took part.

Started

Jun 2019

Finished

Oct 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

16 to 75 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * African American * English speaking * Access to the Internet daily * Reading level of at least 5th grade * Diagnosis of Type 2 Diabetes per one of the following 1. Fasting blood glucose ≥ to 126 mg/dL 2. 2 hr plasma glucose ≥ 200 mg/dL 3. Glycosylated hemoglobin HbA1c ≥ to 6.5% 4. Random plasma glucose ≥ 200 mg/dL Exclusion Criteria: * Glycosylated hemoglobin HbA1c ≤ 7.0 * Pregnancy * Severe visual or hearing impairment or any existing condition that would limit or hinder one's ability to use the Internet * Dementia * Use of supplemental oxygen * Chest pain or angina * Prior lower extremity amputation * A diagnosis of a life threatening malignancy within the past year

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Diabetes mellitus, type 2 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Diabetes mellitus, type 2

Contacts and locations

Locations

  • University of Kansas Medical Center

    Wichita, Kansas, 67214, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.